BFNH insider filings
BIOFORCE NANOSCIENCES HOLDINGS, INC. — 12 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-02. Screen BFNH transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing by 1 insider — 26,700,000 shares, $400,500 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 26,700,000 shares @ $0.01 ($400,500) by Ferguson Merle, filed 2026-09-02.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Ferguson Merle — Director | 1 | — | 1 leg · 26,700,000 sh · $400,500 | 2 |
| KAISER RICHARD KAISER — CEO & CFO, Director | 1 | — | — | 3 |
Recent insider filings — BIOFORCE NANOSCIENCES HOLDINGS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Ferguson Merle — Director | Gift (G): 20,580,000 @ $0.01 · Gift (G): 4,132,000 @ $0.00 · Sale (S): 26,700,000 @ $0.01 | EDGAR |
| 2026-09-02 | 4 | KAISER RICHARD KAISER — CEO & CFO, Director | Gift (G): 4,132,000 @ $0.00 · Other (J): 38,462 @ $0.65 · Grant/award (A): 316,909 @ $0.55 | EDGAR |
| 2023-10-18 | 4 | Ferguson Merle — CEO, Director, 10% owner | Gift (G): 1,470,000 @ $0 · Gift (G): 1,470,000 @ $0 · Gift (G): 1,400,000 @ $0 | EDGAR |
| 2023-10-18 | 4 | Ferguson Merle — CEO, Director, 10% owner | Gift (G): 500,000 @ $0 | EDGAR |
| 2022-12-14 | 4 | Ferguson Merle — CEO, Director, 10% owner | Gift (G): 20,000 @ $0 | EDGAR |
| 2022-10-03 | 4 | Ferguson Merle — CEO, Director, 10% owner | Gift (G): 10,000 @ $0 | EDGAR |
| 2020-12-09 | 4/A | KAISER RICHARD KAISER — CFO, Director, 10% owner | Grant/award (A): 3,000,000 @ $0.00 · Option exercise (M): 500,000 (derivative) @ $0.00 | EDGAR |
| 2020-12-09 | 4/A | Ferguson Merle — CEO, Director, 10% owner | Grant/award (A): 11,000,000 @ $0.00 · Option exercise (M): 1,500,000 (derivative) @ $0.00 | EDGAR |
| 2020-12-09 | 4/A | KAISER RICHARD KAISER — CFO, Director, 10% owner | Grant/award (A): 3,000,000 @ $0.00 · Option exercise (M): 500,000 (derivative) @ $0.00 | EDGAR |
| 2020-12-07 | 4 | KAISER RICHARD KAISER — CFO, Director, 10% owner | Grant/award (A): 3,000,000 @ $0.00 · Option exercise (M): 500,000 (derivative) @ $0.00 | EDGAR |
| 2020-12-07 | 4/A | KAISER RICHARD KAISER — CFO, Director, 10% owner | Grant/award (A): 3,000,000 @ $0.00 · Option exercise (M): 500,000 (derivative) @ $0.00 | EDGAR |
| 2020-12-07 | 4/A | Ferguson Merle — CEO, Director, 10% owner | Grant/award (A): 11,000,000 @ $0.00 · Option exercise (M): 1,500,000 (derivative) @ $0.00 | EDGAR |
Recent 8-K events — BIOFORCE NANOSCIENCES HOLDINGS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-04 | 8-K | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-08-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-07 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-11-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-06-02 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BFNH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs